This inventor holds 1 USPTO granted patent. Top assignee: Cosmo Bio Co., Ltd.. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: Hiroyuki Okamoto: Innovator in Monoclonal Antibody Technology
Introduction
Hiroyuki Okamoto is a distinguished inventor based in Toyonaka, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. His innovative work has the potential to enhance the detection of exosomes, which are crucial in various biological processes.
Latest Patents
Hiroyuki Okamoto holds a patent for a monoclonal antibody designed for detecting exosomes. This antibody is capable of recognizing specific amino acid sequences, which allows for the detection of CD9, CD63, or CD81 on exosomes in a living body. The patent highlights the antibody's excellent sensitivity and specificity, making it a valuable tool in biomedical research.
Career Highlights
Okamoto is currently associated with Cosmo Bio Co., Ltd., where he continues to advance his research in monoclonal antibodies. His work has garnered attention for its potential applications in diagnostics and therapeutic interventions.
Collaborations
He has collaborated with notable colleagues, including Hideki Ohta and Chihiro Okada, to further enhance the impact of his research in the field.
Conclusion
Hiroyuki Okamoto's contributions to monoclonal antibody technology represent a significant advancement in the detection of exosomes. His innovative approach and collaboration with esteemed colleagues underscore the importance of teamwork in scientific research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile